MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    How efficient is subthalamic deep brain stimulation in reducing dyskinesia in Parkinson’s Disease?

    N. Kovacs, A. Juhász, I. Balás (Pecs, Hungary)

    Objective: The aim of this study was to determine whether the UDysRS can detect improvement in dyskinesia reliably after bilateral subthalamic nucleus DBS for PD.…
  • 2017 International Congress

    Neuropsychological predictors of patient-reported cognitive outcomes following deep brain stimulation

    K. Mills, K. Donohue, A. Swaminathan, J.-M. Leoutsakos, J. Brandt (Baltimore, MD, USA)

    Objective: To identify preoperative cognitive performance measures associated with patient- and/or caregiver-reported cognitive decline following deep brain stimulation (DBS) surgery for movement disorders. Background: Patients…
  • 2017 International Congress

    Cognitive effects of GPi versus STN deep brain stimulation in Parkinson’s Disease: experience with patients with moderate cognitive impairment

    C. Marques-Matos, C. Sousa, J. Lima, P. Monteiro, P. Linhares, R. Vaz, M.J. Rosas (Porto, Portugal)

    Objective: To compare the cognitive effects of GPi versus STN deep brain stimulation for PD in patients with moderate cognitive impairment. Background: Patients with moderate…
  • 2017 International Congress

    Electrode Impedance as a marker for “on” and “off” states in a Deep Brain Stimulation cohort: A pilot study

    W. Deeb, J. Shute, M. Okun (Gainesville, FL, USA)

    Objective: To determine the possible use of electrical impedance as an easily measured surrogate measure for clinical changes in patients with Parkinson’s disease (PD) with…
  • 2017 International Congress

    Combined Surgical Therapies for Optimal Management of Advanced Parkinson’s Disease

    L. Kirkpatrick, Y. Torres-Yaghi, A. Keys, N. Starr, T. Kimbason, C. Moussa, F. Amjad, F. Pagan (Washington, DC, USA)

    Objective: We report a case of a patient with advanced PD who began LCIG for refractory motor fluctuations while continuing longstanding STN-DBS. Background: LCIG and…
  • 2017 International Congress

    Prevalence of Parkinson’s disease and Drug-induced Parkinsonism from National Health Insurance Service Claims Data (NHISCD)

    H.-I. MA, S. Jang, J.-s. Kim, S.J. Chung, J.S. Baik, Y.J. Kim (Anyang, Republic of Korea)

    Objective: To evaluate the prevalence and characteristics of of drug induced parkinsonism Background: Drug induced parkinsonism (DIP) is a clinically important disease because it can…
  • 2017 International Congress

    Imbalance between dopaminergic and cholinergic neurotransmission following rotenone administration suggestive of Parkinson’s-like symptoms in male rats

    S. Madiha, S. Haider (Karachi, Pakistan)

    Objective: In the present study we analyzed rotenone-induced gait abnormalities, muscular weakness and locomotor deficits in rats. The study also evaluated the effects of rotenone…
  • 2017 International Congress

    Using the power of a Network to accomplish a Countrywide Review of Acute Parkinson’s Disease management

    E. Peter, B. Mohamed, C. Thomas (Bridgend, United Kingdom)

    Objective: To undertake a review of acute Parkinson’s management across different sites in Wales, a country that is part of the United Kingdom with a…
  • 2017 International Congress

    Haploinsufficiency of KMT2B causes myoclonus-dystonia with impaired psychomotor ability

    T. Kawarai, R. Miyamoto, H. Mure, R. Morigaki, R. Oki, A. Orlacchio, R. Koichihara, E. Nakagawa, T. Sakamoto, Y. Izumi, S. Goto, R. Kaji (Tokushima, Japan)

    Objective: To investigate the genetic defect in patients with early-onset dystonia and myoclonus accompanying various neurological features. Background: Unlike other Mendelian disorders, dystonia genetics has…
  • 2017 International Congress

    The Long-Term Safety of Deutetrabenazine for Chorea in Huntington Disease

    S. Frank, C. Vaughan, D. Stamler, D. Oakes, M. Davis, S. Eberly, E. Kayson, J. Whaley, J. Goldstein, C. Testa (Boston, MA, USA)

    Objective: To evaluate the safety and tolerability of deutetrabenazine in Huntington Disease (HD) over long term exposure. Background: In a randomized, double-blind, controlled trial (First-HD),…
  • « Previous Page
  • 1
  • …
  • 127
  • 128
  • 129
  • 130
  • 131
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • #25179 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley